Epidemiology and clinical outcomes of invasive pulmonary aspergillosis: A nationwide multicenter study in Korea

Infection and Chemotherapy

Volumn 44, Issue 4, 2012, Pages 282-288

  Kim, Sung Han ^a   Moon, Song Mi ^a   Han, Sang Hoon ^b   Chung, Jin Won ^c   Moon, Soo Youn ^d   Lee, Mi Suk ^d   Choo, Eun Ju ^e   Choi, Young Hwa ^e   Kim, Shin Woo ^f   Bae, In Gyu ^g   Kwon, Hyun Hee ^h,i   Peck, Kyong Ran ^j   Kim, Yang Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

^d Kyung Hee University Hospital   (South Korea)

^e Soonchunhyang University College of Medicine   (South Korea)

^f Ajou University School of Medicine   (South Korea)

^g Kyungpook National University School of Medicine   (South Korea)

^h Gyeongsang National University School of Medicine   (South Korea)

ⁱ Catholic University of Daegu   (South Korea)

^j Sungkyunkwan University School of Medicine   (South Korea)

more..

Author keywords

Epidemiology; Invasive pulmonary aspergillosis; Outcome

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CORTICOSTEROID; GALACTOMANNAN; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLUS; BODY FLUID; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FATALITY; FUNGUS CULTURE; FUNGUS ISOLATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KOREA; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORTALITY; MULTICENTER STUDY; NEUTROPENIA; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PHYSICIAN; PLEURA EFFUSION; SALVAGE THERAPY; SENSITIVITY ANALYSIS; SPUTUM;

EID: 84866912528     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2012.44.4.282     Document Type: Article

References (18)

1. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Mũoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
2. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010;50:1091-100.
3. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010;50:1101-111.
4. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Park SW, Choe YJ, Oh MD, Choe KW. Clinical manifestations and treatment outcome of invasive aspergillosis. Korean J Infect Dis 2002;34:160-6.
5. Kim JM, Kwon CH, Joh JW, Song S, Shin M, Kim SJ, Hong SH, Kim BN, Lee SK. Aspergillosis in liver transplant recipients: a single center experience. J Korean Surg Soc 2010;79:267-74.
6. Yoo JH, Choi JH, Lee DG, Choi S, Shin WS, Kim CC. Analysis of invasive fungal infection after hematopoietic stem cell transplantation or chemotherapy in patients with hematologic disease. Infect Chemother 2004;36:40-5.
7. Park SY, Kim SH, Choi SH, Sung H, Kim MN, Woo JH, Kim YS, Park SK, Lee JH, Lee KH, Lee SG, Han DJ, Lee SO. Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients. Transpl Infect Dis 2010;12:309-15.
8. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive apsergillosis. Lancet Infect Dis 2005;5:609-22.
9. Kim SH, Kim MN, Lee SO, Choi SH, Kim YS, Woo JH, Lim CM, Koh Y, Hong SB. Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis. Mycoses 2012;55:189-92.
10. Park SY, Lim C, Lee SO, Choi SH, Kim YS, Woo JH, Song JW, Kim MY, Chae EJ, Do KH, Song KS, Seo JB, Kim SH. Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value. J Infect 2011;63:447-56.
11. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using galactomannan assay: a meta-analysis. Clin Infect Dis 2006;42:1417-27.
12. Park SY, Lee SO, Choi SH, Sung H, Kim MN, Choi CM, Hong SB, Oh YM, Shim TS, Koh Y, Kim YS, Woo JH, Kim SH. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect 2010;61:492-8.
13. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 2009;47:129-33.
14. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF; Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60.
15. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15.
16. Woods G, Miceli MH, Grazziutti ML, Zhao W, Barlogie B, Anaissie E. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer 2007;110:830-4.
17. Maertens J, Buve K, Theunissen K, et al. Galactomannan serves as surrogate endpoint for outcome of pulmonary aspergillosis in neutropenic hematologic patients. Cancer 2009;115:355-62.
18. Mennink-Kersten MA, Donnelly JP, Verweiij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004;4:349-57.